Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A49639 | 35683431 | J Clin Med | Triglyceride and Glucose Index as a Screening Tool for Nonalcoholic Liver Disease in Patients with Metabolic Syndrome. | 2022 | Details |
| A49640 | 35682957 | Int J Mol Sci | Smad3 Phospho-Isoform Signaling in Nonalcoholic Steatohepatitis. | 2022 | Details |
| A49648 | 35680169 | Clin Mol Hepatol | The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults. | 2022 | Details |
| A49654 | 35677722 | Front Endocrinol (Lausanne) | Lower Circulating Leptin Levels Are Related to Non-Alcoholic Fatty Liver Disease in Children With Obesity. | 2022 | Details |
| A49665 | 35677177 | Comput Math Methods Med | Effect of Probiotics Therapy on Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A49668 | 35676065 | Magn Reson Med Sci | The Accuracy and Clinical Relevance of the Multi-echo Dixon Technique for Evaluating Changes to Hepatic Steatosis in Patients with Non-alcoholic Fatty Liver Disease Treated with Formulated Food. | 2022 | Details |
| A49669 | 35675800 | Cell Metab | Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia. | 2022 | Details |
| A49672 | 35674697 | Obesity (Silver Spring) | Triglyceride and glucose index is a simple and easy-to-calculate marker associated with nonalcoholic fatty liver disease. | 2022 | Details |
| A49677 | 35673435 | J Diabetes Metab Disord | The triglyceride-glucose index as a clinical useful marker for metabolic associated fatty liver disease (MAFLD): a population-based study among Iranian adults. | 2022 | Details |
| A49679 | 35672633 | Environ Sci Pollut Res Int | Microarray analysis of mRNA expression profiles in liver of ob/ob mice with real-time atmospheric PM2.5 exposure. | 2022 | Details |
| A49680 | 35672623 | Dig Dis Sci | Histologic Severity of Nonalcoholic Fatty Liver Disease Associates with Reduced Bone Mineral Density in Children. | 2022 | Details |
| A49683 | 35672152 | Pharm Biol | Camel milk protein hydrosylate alleviates hepatic steatosis and hypertension in high fructose-fed rats. | 2022 | Details |
| A49685 | 35671811 | Life Sci | Vildagliptin alleviates liver fibrosis in NASH diabetic rats via modulation of insulin resistance, oxidative stress, and inflammatory cascades. | 2022 | Details |
| A49690 | 35669067 | Front Nutr | Effects of Synbiotics, Probiotics, and Prebiotics on Liver Enzymes of Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Network Meta-Analysis. | 2022 | Details |
| A49693 | 35668285 | Hepatol Int | Chronic intermittent hypoxia contributes to non-alcoholic steatohepatitis progression in patients with obesity. | 2022 | Details |
| A49694 | 35667460 | Int J Biol Macromol | Chondroitin sulfate stimulates the secretion of H2S by Desulfovibrio to improve insulin sensitivity in NAFLD mice. | 2022 | Details |
| A49698 | 35665440 | J Cell Mol Med | Mechanisms of Gynostemma pentaphyllum against non-alcoholic fibre liver disease based on network pharmacology and molecular docking. | 2022 | Details |
| A49703 | 35664038 | World J Gastroenterol | Mechanisms of ductular reaction in non-alcoholic steatohepatitis. | 2022 | Details |
| A49704 | 35663787 | Int J Pediatr Adolesc Med | Treatment of hyperglycemia not associated with NAFLD improvement in children with type 2 diabetes mellitus. | 2021 | Details |
| A49705 | 35663319 | Front Endocrinol (Lausanne) | High Prevalence of Cardiometabolic Comorbidities Among Children and Adolescents With Severe Obesity From a Large Metropolitan Centre (Hangzhou, China). | 2022 | Details |
| A49706 | 35663311 | Front Endocrinol (Lausanne) | Metabolic Stress Index Including Mitochondrial Biomarker for Noninvasive Diagnosis of Hepatic Steatosis. | 2022 | Details |
| A49709 | 35662921 | Front Nutr | High Protein Diets Improve Liver Fat and Insulin Sensitivity by Prandial but Not Fasting Glucagon Secretion in Type 2 Diabetes. | 2022 | Details |
| A49719 | 35659558 | BMC Cardiovasc Disord | The correlation of atherosclerosis and triglyceride glucose index: a secondary analysis of a national cross-sectional study of Japanese. | 2022 | Details |
| A49721 | 35657697 | Diabetes | Regulation of Hepatic Lipid and Glucose Metabolism by INSP3R1. | 2022 | Details |
| A49722 | 35657688 | Diabetes | The Liver-Alpha Cell Axis in Health and in Disease. | 2022 | Details |
| A49725 | 35657127 | Arch Endocrinol Metab | Risk factors associated with nonalcoholic fatty liver disease evaluated by elastography in patients with type 2 diabetes. | 2022 | Details |
| A49738 | 35654225 | Mol Cell Endocrinol | Treatment with spexin mitigates diet-induced hepatic steatosis in vivo and in vitro through activation of galanin receptor 2. | 2022 | Details |
| A49739 | 35654114 | Metabolism | GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease. | 2022 | Details |
| A49743 | 35651973 | Front Endocrinol (Lausanne) | Contribution of Liver and Pancreatic Islet Crosstalk to β-Cell Function/Dysfunction in the Presence of Fatty Liver. | 2022 | Details |
| A49748 | 35650449 | Pharm Res | Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review. | 2022 | Details |
| A49754 | 35646540 | Acta Pharm Sin B | Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases. | 2021 | Details |
| A49756 | 35646271 | World J Hepatol | Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations. | 2022 | Details |
| A49767 | 35643859 | Lab Invest | A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis. | 2022 | Details |
| A49775 | 35642168 | Sichuan Da Xue Xue Bao Yi Xue Ban | [Research Progress in High-Sugar Diet and Inflammatory Diseases]. | 2022 | Details |
| A49778 | 35640037 | Hum Reprod | Comparison of the cardiometabolic profiles of adolescents conceived through ART with those of a non-ART cohort. | 2022 | Details |
| A49779 | 35639744 | PLoS One | A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis. | 2022 | Details |
| A49783 | 35639037 | J Physiol Pharmacol | Are insulin resistance and non-alcoholic fatty liver disease associated with Peyronie's disease? A pilot study. | 2022 | Details |
| A49792 | 35636169 | Phytomedicine | Pharmacological effects of polydatin in the treatment of metabolic diseases: A review. | 2022 | Details |
| A49798 | 35634707 | Gut Microbes | Interaction effect between NAFLD severity and high carbohydrate diet on gut microbiome alteration and hepatic de novo lipogenesis. | 2022 | Details |
| A49800 | 35634340 | Front Immunol | The Potential Role of Gut Microbial-Derived Exosomes in Metabolic-Associated Fatty Liver Disease: Implications for Treatment. | 2022 | Details |
| A49810 | 35630058 | Medicina (Kaunas) | Chronic Inflammation-A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue. | 2022 | Details |
| A49812 | 35629938 | Metabolites | Individuals with Metabolic Syndrome Show Altered Fecal Lipidomic Profiles with No Signs of Intestinal Inflammation or Increased Intestinal Permeability. | 2022 | Details |
| A49813 | 35629915 | Metabolites | Renin-Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins. | 2022 | Details |
| A49818 | 35628889 | J Clin Med | Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Women: Effects of Lifestyle Modifications. | 2022 | Details |
| A49825 | 35626354 | Diagnostics (Basel) | Characteristics of Urine Organic Acid Metabolites in Nonalcoholic Fatty Liver Disease Assessed Using Magnetic Resonance Imaging with Elastography in Korean Adults. | 2022 | Details |
| A49827 | 35625927 | Biomedicines | A Nine-Strain Bacterial Consortium Improves Portal Hypertension and Insulin Signaling and Delays NAFLD Progression In Vivo. | 2022 | Details |
| A49828 | 35625920 | Biomedicines | Premenopausal Syndrome and NAFLD: A New Approach Based on Gender Medicine. | 2022 | Details |
| A49838 | 35624769 | Antioxidants (Basel) | Ramulus Mori (Sangzhi) Alkaloids Alleviate High-Fat Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice. | 2022 | Details |
| A49842 | 35624499 | Genes Environ | SIRT1 mediates nutritional regulation of SREBP-1c-driven hepatic PNPLA3 transcription via modulation of H3k9 acetylation. | 2022 | Details |
| A49867 | 35614469 | Cardiovasc Diabetol | The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management. | 2022 | Details |
| A49877 | 35611413 | Turk J Pediatr | Relation of serum irisin levels to obesity and non-alcoholic fatty liver disease. | 2022 | Details |
| A49887 | 35607608 | Diabetes Metab Syndr Obes | Hyperferritinemia Correlates to Metabolic Dysregulation and Steatosis in Chinese Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients. | 2022 | Details |
| A49901 | 35603482 | Hepatology | PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference. | 2022 | Details |
| A49903 | 35603224 | Front Immunol | Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A49910 | 35599922 | Ann Gastroenterol | Emerging advances in the pharmacologic treatment of nonalcoholic steatohepatitis and related cirrhosis. | 2022 | Details |
| A49913 | 35598686 | Gene | Metagenomic identification of gut microbiota distribution on the colonic mucosal biopsy samples in patients with non-alcoholic fatty liver disease. | 2022 | Details |
| A49915 | 35598211 | Orv Hetil | A nem alkoholos zsírmájbetegség és a 2-es típusú cukorbetegség. | 2022 | Details |
| A49922 | 35594708 | Biomed Pharmacother | Exogenous administration of unacylated ghrelin attenuates hepatic steatosis in high-fat diet-fed rats by modulating glucose homeostasis, lipogenesis, oxidative stress, and endoplasmic reticulum stress. | 2022 | Details |
| A49923 | 35594631 | Nutrition | Concentrated fish oil ameliorates non-alcoholic fatty liver disease by regulating fibroblast growth factor 21-adiponectin axis. | 2022 | Details |
| A49931 | 35590219 | Med (N Y) | Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trial. | 2021 | Details |
| A49933 | 35589613 | Diabetes Obes Metab | Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications. | 2022 | Details |
| A49937 | 35588737 | Horm Metab Res | Insulin-Like Growth Factor-I Might be a Predictor for Severe Non-Alcoholic Fatty Liver Disease in Morbidly Obese Patients. | 2022 | Details |
| A49942 | 35586979 | Hepatology | Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor. | 2022 | Details |
| A49955 | 35583480 | J Agric Food Chem | Spermidine Ameliorates Nonalcoholic Steatohepatitis through Thyroid Hormone-Responsive Protein Signaling and the Gut Microbiota-Mediated Metabolism of Bile Acids. | 2022 | Details |
| A49962 | 35581956 | Hepatol Commun | Favorable impact of long-term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5-year follow-up study. | 2022 | Details |
| A49999 | 35566790 | J Clin Med | Triglyceride-Glucose Index for Early Prediction of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of 121,975 Individuals. | 2022 | Details |
| A50003 | 35565930 | Nutrients | Bifidobacterium animalis ssp. lactis MG741 Reduces Body Weight and Ameliorates Nonalcoholic Fatty Liver Disease via Improving the Gut Permeability and Amelioration of Inflammatory Cytokines. | 2022 | Details |
| A50011 | 35563600 | Int J Mol Sci | Chronic Intermittent Hypoxia Exposure Alternative to Exercise Alleviates High-Fat-Diet-Induced Obesity and Fatty Liver. | 2022 | Details |
| A50013 | 35563534 | Int J Mol Sci | Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis. | 2022 | Details |
| A50028 | 35558979 | Transl Pediatr | Whole-exome sequencing establishes a diagnosis of Alstrom syndrome: a case report. | 2022 | Details |
| A50045 | 35547362 | PPAR Res | Molecular Dynamics Simulation and Essential Dynamics of Deleterious Proline 12 Alanine Single-Nucleotide Polymorphism in PPARγ2 Associated with Type 2 Diabetes, Cardiovascular Disease, and Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A50047 | 35546693 | J Coll Physicians Surg Pak | The Relationship Between Lipid Profile and Non-alcoholic Fatty Liver Disease in Children and Adolescents with Obesity. | 2022 | Details |
| A50048 | 35546386 | J Physiol Biochem | The serum uric acid/creatinine ratio is associated with nonalcoholic fatty liver disease in the general population. | 2022 | Details |
| A50049 | 35546181 | Sci Rep | Additional treatment of vitamin D for improvement of insulin resistance in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis. | 2022 | Details |
| A50058 | 35542976 | Ann Palliat Med | A clinical and laboratory-based nomogram for predicting nonalcoholic fatty liver disease in non-diabetic adults: a cross-sectional study. | 2022 | Details |
| A50066 | 35537354 | Prostaglandins Leukot Essent Fatty Acids | Influence of the nutritional status and oxidative stress in the desaturation and elongation of n-3 and n-6 polyunsaturated fatty acids: Impact on non-alcoholic fatty liver disease. | 2022 | Details |
| A50068 | 35537139 | Food Funct | Corn peptides improved obesity-induced non-alcoholic fatty liver disease through relieving lipid metabolism, insulin resistance and oxidative stress. | 2022 | Details |
| A50069 | 35536225 | J Agric Food Chem | Caffeine Ameliorates AKT-Driven Nonalcoholic Steatohepatitis by Suppressing De Novo Lipogenesis and MyD88 Palmitoylation. | 2022 | Details |
| A50079 | 35535063 | J Clin Exp Hepatol | Gallstone Disease in Cirrhosis-Pathogenesis and Management. | 2021 | Details |
| A50080 | 35534573 | Nat Rev Endocrinol | Macrophage functional diversity in NAFLD - more than inflammation. | 2022 | Details |
| A50084 | 35533183 | PLoS One | Insights from a high-fat diet fed mouse model with a humanized liver. | 2022 | Details |
| A50087 | 35532850 | Hormones (Athens) | Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease. | 2022 | Details |
| A50095 | 35528989 | J Clin Transl Hepatol | Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies. | 2022 | Details |
| A50096 | 35528987 | J Clin Transl Hepatol | Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. | 2022 | Details |
| A50102 | 35528151 | Acta Clin Croat | CROATIAN GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE. | 2021 | Details |
| A50112 | 35521658 | Antioxid Redox Signal | RGS7-ATF3-Tip60 Complex Promotes Hepatic Steatosis and Fibrosis by Directly Inducing TNFα. | 2022 | Details |
| A50115 | 35517895 | Adv Pharm Bull | Protective Role of trans-Chalcone against the Progression from Simple Steatosis to Non-alcoholic Steatohepatitis: Regulation of miR-122, 21, 34a, and 451. | 2021 | Details |
| A50116 | 35517790 | Front Pharmacol | FGF9 Alleviates the Fatty Liver Phenotype by Regulating Hepatic Lipid Metabolism. | 2022 | Details |
| A50123 | 35512974 | Fertil Steril | Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome. | 2022 | Details |
| A50127 | 35510379 | J Food Biochem | Major royal jelly proteins alleviate non-alcoholic fatty liver disease in mice model by regulating disordered metabolic pathways. | 2022 | Details |
| A50134 | 35508191 | Am J Physiol Cell Physiol | The role of mitochondria in the pathophysiology and treatment of common metabolic diseases in humans. | 2022 | Details |
| A50137 | 35507279 | Curr Atheroscler Rep | Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50148 | 35503180 | Adv Exp Med Biol | Manifold Roles of Ceramide Metabolism in Non-Alcoholic Fatty Liver Disease and Liver Cancer. | 2022 | Details |
| A50151 | 35502176 | Evid Based Complement Alternat Med | The Mechanism of Dendrobium officinale as a Treatment for Hyperlipidemia Based on Network Pharmacology and Experimental Validation. | 2022 | Details |
| A50152 | 35501558 | Curr Obes Rep | Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50157 | 35500802 | J Ethnopharmacol | Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice. | 2022 | Details |
| A50160 | 35499800 | Biol Trace Elem Res | Selenium-Enriched Probiotic Alleviates Western Diet-Induced Non-alcoholic Fatty Liver Disease in Rats via Modulation of Autophagy Through AMPK/SIRT-1 Pathway. | 2022 | Details |
| A50162 | 35498403 | Front Endocrinol (Lausanne) | Circulating microRNAs Are Associated With Metabolic Markers in Adolescents With Hepatosteatosis. | 2022 | Details |
| A50166 | 35494531 | Diabetes Metab Syndr Obes | Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome. | 2022 | Details |
| A50170 | 35492013 | Br J Nutr | A healthy lifestyle during adolescence was inversely associated with fatty liver indices in early adulthood - findings from the DONALD cohort study. | 2022 | Details |